Arvee Laboratories Intrinsic Value
Arvee Laboratories (ARVEE) median intrinsic value is ₹52.22 from 9 valuation models (range ₹35–₹87), vs current price ₹174.06 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit ARVEE share price screener.
ARVEE Valuation Methods Summary — DCF, Graham Number & P/E
Arvee Laboratories intrinsic value across 9 models vs current price ₹174.06 — upside/downside and value range per method. See ARVEE price book multiple to compare market price against book value per share.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹52.22 | ₹41.78 - ₹62.66 | -70.0% | EPS: ₹3.70, Sector P/E: 12x |
| Book Value Method | asset | ₹34.81 | ₹31.33 - ₹38.29 | -80.0% | Book Value/Share: ₹30.91, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹52.22 | ₹47.00 - ₹57.44 | -70.0% | Revenue/Share: ₹38.18, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹69.62 | ₹62.66 - ₹76.58 | -60.0% | EBITDA: ₹6.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹69.62 | ₹55.70 - ₹83.54 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹52.22 | ₹47.00 - ₹57.44 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹52.22 | ₹47.00 - ₹57.44 | -70.0% | Revenue Growth: -9.6%, Adj P/E: 8.0x |
| ROE Based Valuation | profitability | ₹87.03 | ₹78.33 - ₹95.73 | -50.0% | ROE: 11.8%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹52.22 | ₹47.00 - ₹57.44 | -70.0% | EPS: ₹3.70, BVPS: ₹30.91 |
ARVEE Intrinsic Value vs Market Price — All Valuation Models
Arvee Laboratories fair value range ₹35–₹87 vs current market price ₹174.06 across 9 valuation models. Check ARVEE company valuation to track the company's total market size over time.
ARVEE Intrinsic Value Analysis — Undervalued or Overvalued?
Arvee Laboratories median intrinsic value ₹52.22, current price ₹174.06 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of ARVEE?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Arvee Laboratories (ARVEE) is ₹52.22 (median value). With the current market price of ₹174.06, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹34.81 to ₹87.03, indicating ₹34.81 - ₹87.03.
Is ARVEE undervalued or overvalued?
Based on our multi-method analysis, Arvee Laboratories (ARVEE) appears to be trading above calculated value by approximately 70.0%.
ARVEE Financial Health — Key Ratios vs Industry Benchmarks
Arvee Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 12.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 11.8% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 11.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.98x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
ARVEE Cash Flow Quality — Operating & Free Cash Flow
Arvee Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹0 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹4 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |